Dr. Michael Kashgarian

Bio

There is no substitute for experience. It's what makes Michael Kashgarian, M.D., valuable.

Kashgarian used his 50-plus years of studying cancers like mesothelioma to become one of the most respected research scientists in the world, contributing to the prestige of Yale University's medical community.

For years he was part of the research that brought awareness to mesothelioma and why treatments that were used for other cancers were ineffective for mesothelioma.

His research included the pathology of mesothelioma and other thoracic cancers, and his pathology work helped develop better ways of delivering radiation therapy, different drugs to use and newer surgical techniques to fight a myriad of diseases.

Kashgarian also has contributed to the current research that focuses on the genetic composition of mesothelioma.

Now a professor emeritus of pathology, as well as a senior research scientist, Kashgarian remains a part of the work he did for so many years at Yale, serving as the pioneer that others are following.

He even established a diagnostic renal pathology and electron microscopy laboratory that now bears his name at the school.

In 2010, he was the centerpiece of a Yale medical symposium honoring his decades of wide-ranging work.

Although officially retired, he continues to work, completing his remaining research grants and maintaining hospital affiliations with the Yale University School of Medicine and the VA Connecticut Health Care System in West Haven.

Publications

Kashgarian's feature publications have discussed relevant issues in immunology and tissue damage after cancer treatment.